Literature DB >> 21766192

Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of law.

Graeme Laurie1.   

Abstract

Although a few jurisdictions around the world have legislated in response to the phenomenon of biobanking, the far more common response has been policy led with funders and other stakeholders initiating multi-level policy initiatives to guide biobanking practice. An example of this is UK Biobank which has developed and operates according to an Ethics and Governance Framework. Such an instrument has no basis in law and yet it has played a crucial role in the set up and ongoing management of the resource. It will continue to do so, as related policies emerge, such as access and intellectual property policies. Numerous biobanking initiatives have similar high-level policy documents that guide decisions and practice. These are often framed as a commitment to participants, researchers and society more broadly and invoke notions such as the public good and the public interest. As such, they serve as a benchmark against which to measure a biobank's performance. Moreover, policies become an important means by which biobankers are held accountable. This article critically analyses this policy-driven phenomenon asking how effectively policy--often as an alternative to law--serves to police and to promote biobanking. It argues that a policy of reflexive governance--defined and developed herein--can best meet the challenges faced by many biobanks and without the need for recourse to law.

Entities:  

Mesh:

Year:  2011        PMID: 21766192     DOI: 10.1007/s00439-011-1066-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  The value of using top-down and bottom-up approaches for building trust and transparency in biobanking.

Authors:  Eric M Meslin
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

2.  Structuring public engagement for effective input in policy development on human tissue biobanking.

Authors:  Kieran C O'Doherty; A Hawkins
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

3.  Inter- and intra-biobank networks: classification of biobanks.

Authors:  Darren Shickle; Marcus Griffin; Karen El-Arifi
Journal:  Pathobiology       Date:  2010-07-07       Impact factor: 4.342

4.  A conceptual framework for genetic policy: comparing the medical, public health, and fundamental rights models.

Authors:  L B Andrews
Journal:  Wash Univ Law Q       Date:  2001

5.  Do we need a uniform regulatory system for biobanks across Europe?

Authors:  Jane Kaye
Journal:  Eur J Hum Genet       Date:  2006-02       Impact factor: 4.246

6.  Ethics. Identifiability in genomic research.

Authors:  William W Lowrance; Francis S Collins
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

7.  Partnership in U.K. Biobank: a third way for genomic property?

Authors:  David E Winickoff
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

Review 8.  Genomics and policymaking: from static models to complex systems?

Authors:  Bartha Maria Knoppers
Journal:  Hum Genet       Date:  2009-02-28       Impact factor: 4.132

9.  Transforming the culture of biomedical research from compliance to trustworthiness: insights from nonmedical sectors.

Authors:  Mark Yarborough; Kelly Fryer-Edwards; Gail Geller; Richard R Sharp
Journal:  Acad Med       Date:  2009-04       Impact factor: 6.893

10.  Meeting the governance challenges of next-generation biorepository research.

Authors:  Stephanie M Fullerton; Nicholas R Anderson; Greg Guzauskas; Dena Freeman; Kelly Fryer-Edwards
Journal:  Sci Transl Med       Date:  2010-01-20       Impact factor: 17.956

View more
  23 in total

1.  The art and science of biobanking.

Authors:  Bartha Maria Knoppers; Thomas J Hudson
Journal:  Hum Genet       Date:  2011-07-21       Impact factor: 4.132

2.  "Forward-Thinking" in U.S. Biobanking.

Authors:  R Jean Cadigan; Teresa P Edwards; Dragana Lassiter; Arlene M Davis; Gail E Henderson
Journal:  Genet Test Mol Biomarkers       Date:  2017-01-24

3.  Health Research with Big Data: Time for Systemic Oversight.

Authors:  Effy Vayena; Alessandro Blasimme
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

4.  Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.

Authors:  Edward S Dove; Samer A Faraj; Eugene Kolker; Vural Ozdemir
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

5.  Power to the people: a wiki-governance model for biobanks.

Authors:  Edward S Dove; Yann Joly; Bartha M Knoppers
Journal:  Genome Biol       Date:  2012-05-29       Impact factor: 13.583

Review 6.  Between Openness and Privacy in Genomics.

Authors:  Effy Vayena; Urs Gasser
Journal:  PLoS Med       Date:  2016-01-12       Impact factor: 11.069

7.  An "Ethical Moment" in Data Sharing.

Authors:  Catherine Heeney
Journal:  Sci Technol Human Values       Date:  2016-05-13

Review 8.  Consent, ethics and genetic biobanks: the case of the Athlome project.

Authors:  Rachel Thompson; Michael J McNamee
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

9.  'Pop-Up' Governance: developing internal governance frameworks for consortia: the example of UK10K.

Authors:  Jane Kaye; Dawn Muddyman; Carol Smee; Karen Kennedy; Jessica Bell
Journal:  Life Sci Soc Policy       Date:  2015-09-28

10.  What Role for Law, Human Rights, and Bioethics in an Age of Big Data, Consortia Science, and Consortia Ethics? The Importance of Trustworthiness.

Authors:  Edward S Dove; Vural Özdemir
Journal:  Laws       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.